These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23783137)

  • 1. Detection, treatment, and prevention of carbapenemase-producing Enterobacteriaceae: recommendations from an International Working Group.
    Levy Hara G; Gould I; Endimiani A; Pardo PR; Daikos G; Hsueh PR; Mehtar S; Petrikkos G; Casellas JM; Daciuk L; Paciel D; Novelli A; Saginur R; Pryluka D; Medina J; Savio E
    J Chemother; 2013 Jun; 25(3):129-40. PubMed ID: 23783137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pediatric case of New Delhi metallo-β-lactamase-1-producing Enterobacteriaceae in the United States.
    Green DA; Srinivas N; Watz N; Tenover FC; Amieva M; Banaei N
    Pediatr Infect Dis J; 2013 Nov; 32(11):1291-4. PubMed ID: 23743543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Options for treating carbapenem-resistant Enterobacteriaceae.
    Rafailidis PI; Falagas ME
    Curr Opin Infect Dis; 2014 Dec; 27(6):479-83. PubMed ID: 25259809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control.
    Tängdén T; Giske CG
    J Intern Med; 2015 May; 277(5):501-12. PubMed ID: 25556628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over-treatment of carbapenemase-producing Enterobacteriaceae.
    Rihani DS; Wallace MR; Sieger BE; Waite RA; Fox M; Brown SA; Deryke CA
    Scand J Infect Dis; 2012 May; 44(5):325-9. PubMed ID: 22200121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibilities of clinical isolates of carbapenemase-producing Enterobacteriaceae to fosfomycin and tigecycline.
    Choudhury S; Yeng JL; Krishnan PU
    Clin Microbiol Infect; 2015 Oct; 21(10):e75-6. PubMed ID: 26086572
    [No Abstract]   [Full Text] [Related]  

  • 7. Breakpoints for carbapenemase-producing Enterobacteriaceae: is the problem solved?
    Cantón R; Canut A; Morosini MI; Oliver A
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():33-40. PubMed ID: 25542050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of multidrug-resistant Enterobacteriaceae.
    Bassetti M; Peghin M; Pecori D
    Curr Opin Infect Dis; 2016 Dec; 29(6):583-594. PubMed ID: 27584587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy for carbapenem-resistant Enterobacteriaceae: increasing evidence, unanswered questions, potential solutions.
    Nabarro LE; Veeraraghavan B
    Eur J Clin Microbiol Infect Dis; 2015 Dec; 34(12):2307-11. PubMed ID: 26363636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
    Stock I
    Med Monatsschr Pharm; 2014 May; 37(5):162-72; quiz 173-4. PubMed ID: 24908928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenges of carbapenemase-producing Enterobacteriaceae and infection prevention: protecting patients in the chaos.
    Savard P; Carroll KC; Wilson LE; Perl TM
    Infect Control Hosp Epidemiol; 2013 Jul; 34(7):730-9. PubMed ID: 23739078
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic options for carbapenemase-producing Enterobacteriaceae].
    Salgado P; Gilsanz F; Maseda E
    Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():12-5. PubMed ID: 26365727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline.
    Garau J
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():198-202. PubMed ID: 18154548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of therapy with aminoglycoside in the outcomes of kidney transplant recipients infected with polymyxin- and carbapenem-resistant Enterobacteriaceae.
    Freire MP; de Oliveira Garcia D; Cury AP; Francisco GR; Dos Santos NF; Spadão F; Bueno MFC; Camargo CH; de Paula FJ; Rossi F; Nahas WC; David-Neto E; Pierrotti LC
    Eur J Clin Microbiol Infect Dis; 2019 Apr; 38(4):755-765. PubMed ID: 30680569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae.
    Berçot B; Poirel L; Dortet L; Nordmann P
    J Antimicrob Chemother; 2011 Oct; 66(10):2295-7. PubMed ID: 21807739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae isolates from 24 hospitals in Belgium.
    Huang TD; Berhin C; Bogaerts P; Glupczynski Y;
    J Antimicrob Chemother; 2013 Aug; 68(8):1832-7. PubMed ID: 23557926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes.
    Falagas ME; Karageorgopoulos DE; Nordmann P
    Future Microbiol; 2011 Jun; 6(6):653-66. PubMed ID: 21707312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control strategies for carbapenemase-producing Enterobacteriaceae at different levels of the healthcare system.
    Asensio Á; Cantero M; Shaw E; Vergara-López S
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():61-6. PubMed ID: 25542054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of invasive carbapenemase-producing Enterobacteriaceae infections in children using carbapenem-aminoglycoside combination therapy: A case series.
    Williams PCM; Bartlett AW; Palasanthiran P; Armstrong B; McMullan BJ
    Infect Dis Health; 2020 Nov; 25(4):314-318. PubMed ID: 32698988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibilities of clinical isolates of ertapenem-non-susceptible Enterobacteriaceae to nemonoxacin, tigecycline, fosfomycin and other antimicrobial agents.
    Hsu MS; Liao CH; Liu CY; Yang CJ; Huang YT; Hsueh PR
    Int J Antimicrob Agents; 2011 Mar; 37(3):276-8. PubMed ID: 21269811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.